Sarepta Therapeutics Inc (SRPT)

Total asset turnover

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Revenue (ttm)	US$ in thousands	1,403,300	1,243,336	1,104,982	1,003,434	975,683	933,013	876,047	835,184	765,786	701,887	645,564	600,082	573,356	540,099	495,074	450,191	407,496	380,833	365,135	344,580
Total assets	US$ in thousands	3,224,380	3,264,580	3,109,710	3,125,890	3,059,790	3,128,370	3,156,150	2,996,850	3,056,150	3,147,970	2,662,220	2,759,070	2,765,230	2,984,720	2,780,660	2,883,040	2,947,390	1,822,820	1,702,470	1,747,750
Total asset turnover		0.44	0.38	0.36	0.32	0.32	0.30	0.28	0.28	0.25	0.22	0.24	0.22	0.21	0.18	0.18	0.16	0.14	0.21	0.21	0.20

March 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $1,403,300K ÷ $3,224,380K
= 0.44

Sarepta Therapeutics Inc's total asset turnover ratio has shown fluctuation over the past few quarters. The company's total asset turnover ratio ranges from 0.14 to 0.44, indicating how efficiently the company generates revenue from its total assets.

The trend in the total asset turnover ratio shows an increase from 0.14 in March 2020 to 0.44 in March 2024, which could suggest an improvement in asset utilization over time. However, there have been ups and downs in the ratio during the period, indicating variability in the company's ability to generate sales from its assets.

Overall, Sarepta Therapeutics Inc's total asset turnover ratio demonstrates a mixed performance in efficiently utilizing its assets to generate revenue. It is essential for the company to continue monitoring and improving this ratio to enhance operational efficiency and financial performance.